WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Theresa HeggieDirector2026-03-2049,933$10.11
$504.82kSell
Theresa HeggieDirector2026-03-2049,933$6.30
$314.58kBuy
Alane P. BarnesChief Legal Officer2026-03-16150,000$9.15
$1.37MSell
Alane P. BarnesChief Legal Officer2026-03-16150,000$5.51
$826.50kBuy
Jon P. StonehouseDirector2026-03-02305,995$3.22
$985.30kBuy
Jon P. StonehouseDirector2026-03-02305,995$8.64
$2.64MSell
Jon P. StonehouseDirector2026-02-27421$8.75
$3.68kBuy
Amy E. McKeeDirector2026-02-27642$8.75
$5.62kBuy
Vincent MilanoDirector2026-02-27848$8.75
$7.42kBuy
Steven FrankDirector2026-02-271,285$8.75
$11.24kBuy

1 of 4

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.88%22,273,375$200.24MInstitution
Baker Bros Advisors LP8.59%21,543,334$193.67MInsider
Blackrock Inc8.43%21,137,791$190.03MInstitution
Ra Capital Management LP6.31%15,827,186$142.29MInstitution
Deerfield Management Company LP5.72%14,341,000$128.93MInstitution
State Street Corp4.42%11,073,211$99.55MInstitution
Kynam Capital Management LP3.73%9,366,526$84.21MInstitution
Janus Henderson Group PLC2.95%7,404,386$66.57MInstitution
Ubs Group Ag2.10%5,263,914$47.32MInstitution
Geode Capital Management LLC2.02%5,053,786$45.43MInstitution

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX83.18%15.30%Net SellingNet Buying
RLAY78.47%21.53%Net SellingNet Selling
RARE83.73%16.27%Net SellingNet Selling
ZLAB2.62%1.78%Net BuyingNet Buying
MLYS69.58%30.42%Net BuyingNet Buying
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 83.18% institutional shareholders, 15.30% Biocryst Pharmaceuticals insiders, and 1.52% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 8.59% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $197.34M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.